Tumor-informed deep sequencing of ctDNA detects minimal residual disease and predicts relapse in osteosarcoma.
Fu Y, Xu Y, Liu W, Zhang J, Wang F, Jian Q, Huang G, Zou C, Xie X, Kim AH, Mathios D, Pang F, Li F, Wang K, Shen J, Yin J.
Fu Y, et al.
EClinicalMedicine. 2024 Jun 20;73:102697. doi: 10.1016/j.eclinm.2024.102697. eCollection 2024 Jul.
EClinicalMedicine. 2024.
PMID: 39022798
Free PMC article.